The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Single Dose Radiotherapy-Global Market Insights and Sales Trends 2024
Synopsis
Single dose radiotherapy has been pitched as an alternative to the conventional radiotherapy for cancer treatment. It has many advantages like less number of visits to the clinic, affordability, less side effects among others.
The global Single Dose Radiotherapy market size is expected to reach US$ 1455.6 million by 2029, growing at a CAGR of 6.6% from 2023 to 2029. The market is mainly driven by the significant applications of Single Dose Radiotherapy in various end use industries. The expanding demands from the Multi-specialty Hospital, Cancer Clinics and Others,, are propelling Single Dose Radiotherapy market. External Beam Radiotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Internal Beam Radiotherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single Dose Radiotherapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single Dose Radiotherapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single Dose Radiotherapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single Dose Radiotherapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single Dose Radiotherapy covered in this report include Varian Medical Systems, Accuray, Elekta, Ion Beam Applications, IsoRay Medical, ViewRay, Hitachi, Provision Healthcare and Mevion Medical Systems, etc.
The global Single Dose Radiotherapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Varian Medical Systems
Accuray
Elekta
Ion Beam Applications
IsoRay Medical
ViewRay
Hitachi
Provision Healthcare
Mevion Medical Systems
Panacea Medical Technologies
Global Single Dose Radiotherapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single Dose Radiotherapy market, Segment by Type:
External Beam Radiotherapy
Internal Beam Radiotherapy
Global Single Dose Radiotherapy market, by Application
Multi-specialty Hospital
Cancer Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single Dose Radiotherapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Single dose radiotherapy has been pitched as an alternative to the conventional radiotherapy for cancer treatment. It has many advantages like less number of visits to the clinic, affordability, less side effects among others.
The global Single Dose Radiotherapy market size is expected to reach US$ 1455.6 million by 2029, growing at a CAGR of 6.6% from 2023 to 2029. The market is mainly driven by the significant applications of Single Dose Radiotherapy in various end use industries. The expanding demands from the Multi-specialty Hospital, Cancer Clinics and Others,, are propelling Single Dose Radiotherapy market. External Beam Radiotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Internal Beam Radiotherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single Dose Radiotherapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single Dose Radiotherapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single Dose Radiotherapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single Dose Radiotherapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single Dose Radiotherapy covered in this report include Varian Medical Systems, Accuray, Elekta, Ion Beam Applications, IsoRay Medical, ViewRay, Hitachi, Provision Healthcare and Mevion Medical Systems, etc.
The global Single Dose Radiotherapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Varian Medical Systems
Accuray
Elekta
Ion Beam Applications
IsoRay Medical
ViewRay
Hitachi
Provision Healthcare
Mevion Medical Systems
Panacea Medical Technologies
Global Single Dose Radiotherapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single Dose Radiotherapy market, Segment by Type:
External Beam Radiotherapy
Internal Beam Radiotherapy
Global Single Dose Radiotherapy market, by Application
Multi-specialty Hospital
Cancer Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single Dose Radiotherapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Single Dose Radiotherapy
1.1 Single Dose Radiotherapy Market Overview
1.1.1 Single Dose Radiotherapy Product Scope
1.1.2 Single Dose Radiotherapy Market Status and Outlook
1.2 Global Single Dose Radiotherapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Single Dose Radiotherapy Market Size by Region (2018-2029)
1.4 Global Single Dose Radiotherapy Historic Market Size by Region (2018-2023)
1.5 Global Single Dose Radiotherapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Single Dose Radiotherapy Market Size (2018-2029)
1.6.1 North America Single Dose Radiotherapy Market Size (2018-2029)
1.6.2 Europe Single Dose Radiotherapy Market Size (2018-2029)
1.6.3 Asia-Pacific Single Dose Radiotherapy Market Size (2018-2029)
1.6.4 Latin America Single Dose Radiotherapy Market Size (2018-2029)
1.6.5 Middle East & Africa Single Dose Radiotherapy Market Size (2018-2029)
2 Single Dose Radiotherapy Market by Type
2.1 Introduction
2.1.1 External Beam Radiotherapy
2.1.2 Internal Beam Radiotherapy
2.2 Global Single Dose Radiotherapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Single Dose Radiotherapy Historic Market Size by Type (2018-2023)
2.2.2 Global Single Dose Radiotherapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Single Dose Radiotherapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Single Dose Radiotherapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Single Dose Radiotherapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Single Dose Radiotherapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Single Dose Radiotherapy Revenue Breakdown by Type (2018-2029)
3 Single Dose Radiotherapy Market Overview by Application
3.1 Introduction
3.1.1 Multi-specialty Hospital
3.1.2 Cancer Clinics
3.1.3 Others
3.2 Global Single Dose Radiotherapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Single Dose Radiotherapy Historic Market Size by Application (2018-2023)
3.2.2 Global Single Dose Radiotherapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Single Dose Radiotherapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Single Dose Radiotherapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Single Dose Radiotherapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Single Dose Radiotherapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Single Dose Radiotherapy Revenue Breakdown by Application (2018-2029)
4 Single Dose Radiotherapy Competition Analysis by Players
4.1 Global Single Dose Radiotherapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Single Dose Radiotherapy as of 2022)
4.3 Date of Key Players Enter into Single Dose Radiotherapy Market
4.4 Global Top Players Single Dose Radiotherapy Headquarters and Area Served
4.5 Key Players Single Dose Radiotherapy Product Solution and Service
4.6 Competitive Status
4.6.1 Single Dose Radiotherapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Varian Medical Systems
5.1.1 Varian Medical Systems Profile
5.1.2 Varian Medical Systems Main Business
5.1.3 Varian Medical Systems Single Dose Radiotherapy Products, Services and Solutions
5.1.4 Varian Medical Systems Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.1.5 Varian Medical Systems Recent Developments
5.2 Accuray
5.2.1 Accuray Profile
5.2.2 Accuray Main Business
5.2.3 Accuray Single Dose Radiotherapy Products, Services and Solutions
5.2.4 Accuray Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.2.5 Accuray Recent Developments
5.3 Elekta
5.3.1 Elekta Profile
5.3.2 Elekta Main Business
5.3.3 Elekta Single Dose Radiotherapy Products, Services and Solutions
5.3.4 Elekta Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.3.5 Ion Beam Applications Recent Developments
5.4 Ion Beam Applications
5.4.1 Ion Beam Applications Profile
5.4.2 Ion Beam Applications Main Business
5.4.3 Ion Beam Applications Single Dose Radiotherapy Products, Services and Solutions
5.4.4 Ion Beam Applications Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.4.5 Ion Beam Applications Recent Developments
5.5 IsoRay Medical
5.5.1 IsoRay Medical Profile
5.5.2 IsoRay Medical Main Business
5.5.3 IsoRay Medical Single Dose Radiotherapy Products, Services and Solutions
5.5.4 IsoRay Medical Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.5.5 IsoRay Medical Recent Developments
5.6 ViewRay
5.6.1 ViewRay Profile
5.6.2 ViewRay Main Business
5.6.3 ViewRay Single Dose Radiotherapy Products, Services and Solutions
5.6.4 ViewRay Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.6.5 ViewRay Recent Developments
5.7 Hitachi
5.7.1 Hitachi Profile
5.7.2 Hitachi Main Business
5.7.3 Hitachi Single Dose Radiotherapy Products, Services and Solutions
5.7.4 Hitachi Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.7.5 Hitachi Recent Developments
5.8 Provision Healthcare
5.8.1 Provision Healthcare Profile
5.8.2 Provision Healthcare Main Business
5.8.3 Provision Healthcare Single Dose Radiotherapy Products, Services and Solutions
5.8.4 Provision Healthcare Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.8.5 Provision Healthcare Recent Developments
5.9 Mevion Medical Systems
5.9.1 Mevion Medical Systems Profile
5.9.2 Mevion Medical Systems Main Business
5.9.3 Mevion Medical Systems Single Dose Radiotherapy Products, Services and Solutions
5.9.4 Mevion Medical Systems Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.9.5 Mevion Medical Systems Recent Developments
5.10 Panacea Medical Technologies
5.10.1 Panacea Medical Technologies Profile
5.10.2 Panacea Medical Technologies Main Business
5.10.3 Panacea Medical Technologies Single Dose Radiotherapy Products, Services and Solutions
5.10.4 Panacea Medical Technologies Single Dose Radiotherapy Revenue (US$ Million) & (2018-2023)
5.10.5 Panacea Medical Technologies Recent Developments
6 North America
6.1 North America Single Dose Radiotherapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Single Dose Radiotherapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Single Dose Radiotherapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Single Dose Radiotherapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Single Dose Radiotherapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Single Dose Radiotherapy Market Dynamics
11.1 Single Dose Radiotherapy Industry Trends
11.2 Single Dose Radiotherapy Market Drivers
11.3 Single Dose Radiotherapy Market Challenges
11.4 Single Dose Radiotherapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
